Renaissance Technologies - HORIZON THERAPEUTICS PUB L ownership

HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HORIZON THERAPEUTICS PUB L
ValueSharesWeighting
Q3 2023$397,204
+12.0%
3,433,349
-0.4%
0.68%
+32.5%
Q2 2023$354,704
-3.5%
3,448,749
+2.4%
0.51%
+4.7%
Q1 2023$367,633
+92.9%
3,368,449
+101.1%
0.49%
+87.0%
Q4 2022$190,621
-99.8%
1,675,049
+7.3%
0.26%
+90.5%
Q3 2022$96,639,000
-30.4%
1,561,466
-10.3%
0.14%
-16.5%
Q2 2022$138,804,000
-34.9%
1,740,266
-14.1%
0.16%
-34.4%
Q1 2022$213,131,000
-13.1%
2,025,766
-11.0%
0.25%
-18.0%
Q4 2021$245,377,000
-31.1%
2,277,066
-30.0%
0.30%
-33.7%
Q3 2021$356,165,000
-10.2%
3,251,463
-23.3%
0.46%
-7.1%
Q2 2021$396,815,000
-17.2%
4,237,663
-18.7%
0.50%
-17.1%
Q1 2021$479,525,000
-3.6%
5,209,963
-23.4%
0.60%
+10.6%
Q4 2020$497,344,000
-27.1%
6,798,963
-22.6%
0.54%
-20.7%
Q3 2020$682,098,000
+19.0%
8,780,875
-14.9%
0.68%
+37.6%
Q2 2020$573,190,000
+82.2%
10,312,875
-2.9%
0.50%
+61.8%
Q1 2020$314,673,000
-13.9%
10,623,675
+5.2%
0.31%
+8.9%
Q4 2019$365,644,000
+43.6%
10,100,675
+8.0%
0.28%
+30.1%
Q3 2019$254,616,000
+20.9%
9,350,575
+6.8%
0.22%
+16.8%
Q2 2019$210,628,0008,754,2750.18%
Other shareholders
HORIZON THERAPEUTICS PUB L shareholders Q1 2022
NameSharesValueWeighting ↓
Kopp Family Office, LLC 544,835$57,322,00030.98%
Paulson & Co. 5,614,000$590,649,00018.18%
Avoro Capital Advisors LLC 6,500,000$683,865,00012.48%
1492 Capital Management LLC 121,840$12,819,0006.80%
Iron Triangle Partners LP 503,744$52,999,0006.30%
Tri Locum Partners LP 132,332$13,923,0005.44%
HealthCor Management, L.P. 710,110$74,711,0004.98%
Eversept Partners, LP 609,939$64,171,6824.93%
Bain Capital Public Equity Management II, LLC 1,286,371$135,339,0004.33%
PFM Health Sciences, LP 1,091,840$114,872,0004.30%
View complete list of HORIZON THERAPEUTICS PUB L shareholders